CCR5 mimicry by sulfated human anti-HIV-1 antibodies
- PMID: 12887913
- DOI: 10.1016/s0092-8674(03)00564-6
CCR5 mimicry by sulfated human anti-HIV-1 antibodies
Abstract
HIV-1 envelope glycoprotein interaction with a principal coreceptor, CCR5, requires sulfated tyrosines on the CCR5 amino terminus. In this issue of Cell, Choe et al. identified tyrosine-sulfated, neutralizing antibodies against HIV-1 that apparently mimic CCR5. The results demonstrate for the first time that a natural posttranslational modification of an antibody can contribute substantially to antigen recognition.
Comment on
-
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.Cell. 2003 Jul 25;114(2):161-70. doi: 10.1016/s0092-8674(03)00508-7. Cell. 2003. PMID: 12887918
Similar articles
-
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.Cell. 2003 Jul 25;114(2):161-70. doi: 10.1016/s0092-8674(03)00508-7. Cell. 2003. PMID: 12887918
-
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.Science. 2007 Sep 28;317(5846):1930-4. doi: 10.1126/science.1145373. Science. 2007. PMID: 17901336 Free PMC article.
-
Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.EBioMedicine. 2016 Aug;10:45-54. doi: 10.1016/j.ebiom.2016.06.037. Epub 2016 Jun 26. EBioMedicine. 2016. PMID: 27389109 Free PMC article.
-
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.Proc Natl Acad Sci U S A. 2000 May 23;97(11):5762-7. doi: 10.1073/pnas.97.11.5762. Proc Natl Acad Sci U S A. 2000. PMID: 10823934 Free PMC article.
-
Antibody-based strategies in HIV therapy.Int J Antimicrob Agents. 2020 Dec;56(6):106186. doi: 10.1016/j.ijantimicag.2020.106186. Epub 2020 Oct 9. Int J Antimicrob Agents. 2020. PMID: 33045349 Free PMC article. Review.
Cited by
-
Cell Proteins Interacting with the Human Immunodeficiency Virus in Immunoblotting can be Detected by R5- or X4- Tropic Human Immunodeficiency Virus Particles.Int J Appl Basic Med Res. 2020 Apr-Jun;10(2):81-85. doi: 10.4103/ijabmr.IJABMR_398_18. Epub 2020 Apr 2. Int J Appl Basic Med Res. 2020. PMID: 32566522 Free PMC article.
-
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies.Nat Commun. 2020 Oct 8;11(1):5066. doi: 10.1038/s41467-020-18828-4. Nat Commun. 2020. PMID: 33033255 Free PMC article.
-
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.J Virol. 2005 Oct;79(19):12231-41. doi: 10.1128/JVI.79.19.12231-12241.2005. J Virol. 2005. PMID: 16160149 Free PMC article.
-
A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production.Front Immunol. 2022 Dec 8;13:1072702. doi: 10.3389/fimmu.2022.1072702. eCollection 2022. Front Immunol. 2022. PMID: 36569848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources